In collaboration with Lindex and Rīga Stradiņš University, Longenesis has launched a digital solution to engage women in breast cancer research and screening.

One of the challenges in oncology prevention is the timely identification of risk factors, as well as broader population proactive engagement and retention rates in preventative campaigns. With the help of digital technologies provided by Longenesis, they empower women to be proactively engaged in hereditary mutation research initiatives and receive a level of personalization and transparency in the process via dynamic e-consent.

On the other side, Longenesis creates a digitized bridge, connecting researchers from Rīga Stradiņš University Institute of Oncology with a broader population, to conduct research on combining phenotypic and genomic with patient-reported outcomes data, aimed to walk hand-in-hand towards a personalized breast oncology screening.

Find out more HERE